8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 2, 2005 (February 2, 2005)

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)

Tennessee	000-22217	62-1493316
(State or Other Jurisdiction of	(Commission	(I.R.S. Employer
Incorporation)	File Number)	Identification No.)

20 Burton Hills Boulevard
Nashville, Tennessee	37215
(Address of Principal Executive Offices)	(Zip Code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under th eExchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

	Item 2.02. Results of Operations and Financial Condition
	Item 7.01. Regulation FD Disclosure
	Item 9.01. Financial Statements and Exhibits
SIGNATURES
INDEX TO EXHIBITS
EX-99 PRESS RELEASE

Item 2.02. Results of Operations and Financial Condition

     On February 2, 2005, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.

Item 7.01. Regulation FD Disclosure

     On February 2, 2005, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.

Item 9.01. Financial Statements and Exhibits

     (c) 99 Press release dated February 2, 2005

2

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMSURG CORP.
By:	/s/ Claire M. Gulmi
	Claire M. Gulmi
	Senior Vice President and Chief Financial Officer (Principal Financial and Duly Authorized Officer)

Date: February 2, 2005

3

INDEX TO EXHIBITS

Exhibit
Number		Description
	99	Press release dated February 2, 2005

4

EX-99

                                                                      EXHIBIT 99
PRESS RELEASE


          AMSURG PREVIEWS FOURTH-QUARTER EARNINGS OF $0.29 PER DILUTED
            SHARE AND REVISES 2005 EARNINGS GUIDANCE FOR ANTICIPATED
                              GROWTH OF 20% TO 23%

                              --------------------

NASHVILLE, Tenn. (February 2, 2005) - Ken P. McDonald, President and Chief
Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced that the
Company expects net earnings per diluted share for the fourth quarter of 2004 of
$0.29. For the year ended December 31, 2004, the Company expects net earnings
per diluted share from continuing operations and adjusted earnings per diluted
share from continuing operations to total $1.09 and $1.11, respectively, within
the Company's established guidance for the year. See page 3 for a reconciliation
of adjusted net earnings from continuing operations to net earnings from
continuing operations. AmSurg plans to announce its fourth quarter results on
February 22, 2005.

         Mr. McDonald remarked, "During the fourth quarter, we opened nine new
centers, including three through de novo development and six through
acquisition. In addition, our fourth-quarter results reflect a 2% increase in
same-facility revenues. Same-facility revenue growth was challenging for the
fourth quarter because of a relatively strong performance for the fourth quarter
of 2003, which included a higher than average revenue per procedure in part due
to the Medicare rate increase in October 2003 that was reversed in 2004. As a
result of this higher average revenue for 2003, there was a disparity between
our same facility procedure growth, which was 4%, and our same facility revenue
growth of 2%. Our same-facility revenue for full year 2004 increased 4%, within
our 4% to 7% range of guidance for the year.

         "After a thorough review of center operations during our recently
completed annual budgeting process, we expect same-facility revenue growth for
2005 in a range of 4% to 7%. However, several factors have emerged since the
beginning of the fourth quarter that have caused us to re-evaluate our
established guidance for 2005 and to revise it more in line with our long-term
annual growth target of 20% plus. Our lower same-facility revenue growth for the
fourth quarter of 2004 resulted in a lower base of revenues from which to begin
2005, thereby reducing our projected revenues for 2005. Our three Florida
centers under development will open later than expected due to hurricane-related
delays in construction, while five other centers under development at year end
will open later than originally scheduled due to various construction and
regulatory review delays. The acquisition of four centers combined in a single
transaction that were expected to be completed in the fourth quarter of 2004
upon the determination of Certificate of Need approval are now expected to close
in the first quarter of 2005. In January 2005 we received CON approval, subject
to the satisfaction of certain administrative requirements, and are moving
towards closing.








                                    - MORE -




AMSG Previews Fourth-Quarter Earnings of $0.29 Per Diluted Share
Page 2
February 2, 2005


         "As a result of the combined impact of these factors, we now expect net
earnings per diluted share for 2005 in a range of $1.33 to $1.36, compared with
the previous range of $1.42 to $1.45. This new guidance represents 20% to 23%
growth from expected adjusted earnings per diluted share from continuing
operations for 2004 of $1.11. In addition, our guidance includes revenues for
2005 in a range of $400 million to $420 million and the addition of 16 to 19 new
centers. This number of new centers expected in 2005 is higher than usual due to
the strength of our acquisition and development pipeline, with eight centers
under development scheduled to open in 2005 and five acquisitions scheduled to
close in the first quarter of 2005."

         AmSurg Corp. will hold a conference call to discuss this release today
at 5:00 p.m. Eastern time. Investors will have the opportunity to listen to the
conference call over the Internet by going to www.amsurg.com and clicking
Investor Relations or by going to www.streetevents.com at least 15 minutes early
to register, download, and install any necessary audio software. For those who
cannot listen to the live broadcast, a replay will be available at these sites
shortly after the call through the end of business on March 2, 2005.

         This press release contains forward-looking statements. These
statements, which have been included in reliance on the "safe harbor" provisions
of the Private Securities Litigation Reform Act of 1995, involve risks and
uncertainties. Investors are hereby cautioned that these statements may be
affected by the important factors, among others, set forth in AmSurg's filings
with the Securities and Exchange Commission, and, consequently, actual
operations and results may differ materially from the results discussed in the
forward-looking statements. Factors that might cause such a difference include,
but are not limited to, the Company's ability to enter into partnership or
operating agreements for new practice-based ambulatory surgery centers; its
ability to identify suitable acquisition candidates and negotiate and close
acquisition transactions, including centers under letter of intent; its ability
to obtain the necessary financing or capital on terms satisfactory to the
Company to execute its expansion strategy; its ability to generate and manage
growth; its ability to contract with managed care payors on terms satisfactory
to the Company for its existing centers and its centers that are currently under
development; its ability to obtain and retain appropriate licensing approvals
for its existing centers and centers currently under development; its ability to
minimize start-up losses of its development centers; the ability of its
physician partners to recruit additional physicians to their practices; its
ability to maintain favorable relations with its physician partners; changes in
the medical staff at its centers; changes in the rate setting methodology,
payment rates, payment policies and the list of covered surgical procedures for
ambulatory surgery centers by the Centers for Medicare & Medicaid Services; the
risk of legislative or regulatory changes that would establish uniform rates for
outpatient surgical services, regardless of setting; risks associated with the
Company's status as a general partner of limited partnerships; the Company's
ability to maintain its technological capabilities in compliance with regulatory
requirements; risks associated with the valuation and tax deductibility of
goodwill; the risk of legislative or regulatory changes that would prohibit
physician ownership in ambulatory surgery centers; and the Company's ability to
obtain the necessary financing to fund the purchase of its physician partners'
minority interests in the event of a regulatory change that would require such a
purchase. AmSurg disclaims any intent or obligation to update these
forward-looking statements.









                                    - MORE -




AMSG Previews Fourth-Quarter Earnings of $0.29 Per Diluted Share
Page 3
February 2, 2005


         AmSurg Corp. develops, acquires and manages physician practice-based
ambulatory surgery centers in partnership with surgical and other group
practices. At December 31, 2004, AmSurg owned a majority interest in 128 centers
and had nine centers under development.

Supplemental Financial Information




Reconciliation of Expected 2004 Adjusted Net                           For the Year Ended
Earnings Per Diluted Share from Continuing Operations: (1)             December 31, 2004
- ----------------------------------------------------------             -----------------
                                                                    
Net earnings per diluted share from
         continuing operations                                                $1.09
Add:  Loss on long-term note receivable,
         net of income taxes                                                   0.02
                                                                              -----
Adjusted net earnings per diluted share from
         continuing operations                                                $1.11
                                                                              =====



(1) Adjusted net earnings per diluted share from continuing operations is a
non-GAAP financial measure. The Company believes its calculation of adjusted net
earnings per diluted share from continuing operations provides a better measure
of the Company's ongoing performance and better comparability to prior periods,
because it excludes an item unrelated to the Company's core business operations.
The adjusted items should not be considered in isolation or as a substitute for
net earnings from continuing operations or net earnings from continuing
operations per diluted share as determined in accordance with accounting
principles generally accepted in the United States.




                                            Contact:
                                                      Claire M. Gulmi
                                                      Senior Vice President and
                                                      Chief Financial Officer
                                                      (615) 665-1283



                                      -END-